EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies

Gabriele Sani iD, Stella Margoni, Andrea Brugnami, Ottavia Marianna Ferrara iD, Evelina Bernardi, Alessio Simonetti, Laura Monti, Marianna Mazza, Delfina Janiri, Lorenzo Moccia, Georgios D Kotzalidis iD, Daniela Pia Rosaria Chieffo und 1 weitere

Antioxidants · 27.03.2023 · 12 (4) · 817

DOI: 10.3390/antiox12040817 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 27.03.2023. Verfasst von Gabriele Sani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Psychiatry, Department of Neuroscience, Catholic University of the Sacred Hearth, Rome, Largo Francesco Vito 1, 00168 Rome, Italy. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is increasing interest in the involvement of antioxidative systems in protecting from depression. Among these, Nrf2 occupies a central place. We aimed to review the role of Nrf2 in depression. For this reason, we conducted a PubMed search using as search strategy (psychiatr*[ti] OR schizo*[ti] OR psychot*[ti] OR psychos*[ti] OR depress*[ti] OR MDD[ti] OR BD[ti] OR bipolar[ti] OR Anxiety[ti] OR antidepress*[ti] OR panic[ti] OR obsess*[ti] OR compulsio*[ti] OR “mood disord*”[ti] OR phobi*[ti] OR agoraphob*[ti] OR anorex*[ti] OR anorect*[ti] OR bulimi*[ti] OR “eating disorder*”[ti] OR neurodevelopm*[ti] OR retardation[ti] OR autism[ti] OR autistic[ti] OR ASM[ti] OR adhd[ti] OR “attention-deficit”[ti]) AND nrf2, which on the 9th of March produced 208 results of which 89 were eligible for our purposes. Eligible articles were studies reporting data of Nrf2 manipulations or content by any treatment in human patients or animals with any animal model of depression. Most studies were on mice only (N = 58), 20 on rats only, and three on both rats and mice. There were two studies on cell lines (in vitro) and one each on nematodes and fish. Only four studies were conducted in humans, one of which was post mortem. Most studies were conducted on male animals; however, human studies were carried out on both men and women. The results indicate that Nrf2 is lower in depression and that antidepressant methods (drugs or other methods) increase it. Antioxidant systems and plasticity-promoting molecules, such as those in the Nrf2–HO-1, BDNF–TrkB, and cyclic AMP–CREB pathways, could protect from depression, while glycogen synthase kinase-3β and nuclear factor κB oppose these actions, thus increasing depressive-like behaviours. Since Nrf2 is also endowed with tumorigenic and atherogenic potential, the balance between benefits and harms must be taken into account in designing novel drugs aiming at increasing the intracellular content of Nrf2.

Schlagwörter

Stichwörter der Autor:innen

Haemoxygenase (HO-1)Nuclear factor erythroid-2 (Nrf2)Nuclear factor kappa B (NF-κB)antioxidant pathwaysdepressionpathophysiology

Autor:innen und Institutionen

  • Institute of Psychiatry, Department of Neuroscience, Catholic University of the Sacred Hearth, Rome, Largo Francesco Vito 1, 00168 Rome, Italy.
  • Department of Psychiatry, Department of Neuroscience, Head, Neck and Thorax, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 1, 00168 Rome, Italy.
  • Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
  • Centro Lucio Bini, Via Crescenzio 42, 00193 Rome, Italy.
  • UOS Clinical Psychology, Clinical Government, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 1, 00168 Rome, Italy.
  • NESMOS Department, Faculty of Medicine and Psychology, Sant'Andrea University Hospital, University of Rome La Sapienza, Via di Grottarossa, 1035-1039, 00189 Rome, Italy.

ORCID-Profile: Gabriele Sani, Ottavia Marianna Ferrara, Georgios D Kotzalidis

Zitieren

APA

Sani, G., Margoni, S., Brugnami, A., Ferrara, O. M., Bernardi, E., Simonetti, A., Monti, L., Mazza, M., Janiri, D., Moccia, L., Kotzalidis, G. D., Chieffo, D. P. R., & Janiri, L. (2023). The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies. Antioxidants, 12(4), 817. https://doi.org/10.3390/antiox12040817

Vancouver

Sani G, Margoni S, Brugnami A, Ferrara OM, Bernardi E, Simonetti A, et al. The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies. Antioxidants. 2023;12(4):817. doi:10.3390/antiox12040817

BibTeX
@article{Sani2023,
  author = {Sani, Gabriele and Margoni, Stella and Brugnami, Andrea and Ferrara, Ottavia Marianna and Bernardi, Evelina and Simonetti, Alessio and Monti, Laura and Mazza, Marianna and Janiri, Delfina and Moccia, Lorenzo and Kotzalidis, Georgios D and Chieffo, Daniela Pia Rosaria and Janiri, Luigi},
  title = {The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies},
  journal = {Antioxidants},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {817},
  doi = {10.3390/antiox12040817}
}
Kostenlos starten →